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ABSTRACT 
 
To elucidate the role of environmental conditions in molecular-level dynamics and to 
study their impact on macroscopic brain tumor growth patterns, the expression of the 
genes Tenascin C and PCNA in a 2D agent-based model for the migratory trait is 
calibrated using experimental data from the literature, while the expression of these genes 
for the proliferative trait is obtained as the model output. Numerical results confirm that 
the gene expression of Tenascin C is consistently higher in the migratory glioma cell 
phenotype and show that the expression of PCNA is consistently higher among 
proliferating tumor cells. Intriguingly, the time series of the tumor cells’ gene expression 
exhibit a sudden change in behavior during the invasion of the tumor into a nutrient-
abundant region, showing a robust positive correlation between the expression of 
Tenascin C and the tumor’s diameter, yet a strong negative correlation between the 
expression of PCNA and the diameter. These molecular-level dynamics correspond to the 
emergence of a structural asymmetry in the form of a bulging tumor rim in the nutrient-
abundant region. Within such geographic regions, the simulated time series thus supports 
the critical role of the migratory cell phenotype during both the tumor system’s overall 
macroscopic expansion and the evolvement of regional growth patterns, particularly in 
the later stages. Furthermore, detrended fluctuation analysis (DFA) suggests that for 
prediction purposes, the simulated gene expression profiles of Tenascin C and PCNA that 
were determined separately for the migrating and proliferating phenotypes exhibit lesser 
predictability than those of the phenotypic mixture combining all viable tumor cells 
typically found in clinical biopsies. Finally, dividing the tumor into distinct geographic 
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regions of interest (ROI) reveals that the gene expression profile of tumor cells residing 
in the quadrant close to the nutrient-abundant region is representative for the entire tumor 
whereas the expression profile of tumor cells residing in the geographically opposite ROI 
is not. Potential implications of these modeling results for experimental and clinical 
cancer research are discussed.    
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1. INTRODUCTION 
 
Despite all efforts, the outcome of patients suffering from highly malignant 
neuroepithelial brain tumors remains dismal. Treatment difficulties arise from the main 
characteristics of these glial tumors such as rapid growth, extensive tissue invasion, and 
cell heterogeneity. Histological and immunocytochemistry methods [1] and more recently 
gene expression arrays [2] reveal that the behavior of these tumor cells appears to exhibit 
a dichotomy between proliferation and migration. That is, the same cell can either 
proliferate or migrate, yet not both at the same time, which should greatly influence the 
spatio-temporal dynamics of the malignant biosystem. Therefore, analyzing the impact of 
environmental factors on gene expression changes, which in turn are expected to regulate 
the phenotypic ‘switch’ from proliferation to migration, is key to a better understanding 
of tumor behavior and necessary in order to develop predictive modeling platforms for 
clinical applications.  
As a first step, we employ here a previously developed 2D agent-based model of a 
virtual multicellular brain tumor system [3,4], which has been augmented to take into 
account explicitly molecular level dynamics. Our modeling platform is particular suitable 
for this purpose due to its ‘monoclonal’ nature, i.e., it focuses on the behavior of a 
population of homogeneous cells. To render our model tractable, the focus of our very 
simplified gene network is centered on the behavior of two genes only, namely Tenascin 
C and PCNA, which are chosen based on their reported roles during proliferation and 
migration of glioma cells. More specifically, Tenascin C is a an extracellular matrix 
glycoprotein known to be over-expressed in human gliomas [5,6]. Further, it has been 
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demonstrated in vitro that migration is stimulated when human SF-767 glioma cells are 
placed on Tenascin C [7]. In contrast, the gene expression of proliferating cell nuclear 
antigen (PCNA) markedly rises during G1/S phase, thus serves as an indicator of 
proliferation activities [8]. High levels of PCNA have been shown to correlate with 
histological grade and poor prognosis in glioma patients [9,10].  
By calibrating the expression of both genes using experimental data for the 
migratory phenotype while generating the gene expression for proliferating and quiescent 
cells as the model output, numerical results of the model confirm that among the 
migratory phenotype the expression of Tenascin C is indeed consistently higher, while 
they reveal the reverse for the proliferating tumor cells, which exhibit consistently higher 
expression of gene PCNA. In our particular modeling setup, this genetic switch, 
determining the cellular phenotype, can be explained by the tendency for migrating cells 
to encounter higher level of hypoxia than their proliferating peers. We then show that 
these molecular level dynamics can be directly linked to the tumor diameter, i.e., to the 
structural characteristic at the multicellular level. More specifically, in the presence of 
abundant nutrients, the gene expression profiles indicate a breaking point in the time 
series after which we find robust (i) positive correlations between tumor diameter and the 
expression of Tenascin C, and (ii) negative correlations between the former and PCNA 
expression, both as statistical averages for the entire pool of viable tumor cells. 
Furthermore, during tumor invasion towards the geographic region of abundant nutrients, 
these molecular dynamics are accompanied by the emergence of a structural asymmetry 
in the rim of the growing tumor. The numerical results therefore support the notion that in 
the presence of these distinct microenvironmental conditions the migratory phenotype is 
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crucial for the tumor system’s macrocopic expansion and its regional structural patterns. 
In addition, detrended fluctuation analysis (DFA) suggests that the gene expression 
profile of a phenotypically mixed cell population has a higher predictive value than that 
of a virtual tumor specimen that is divided into separate migrating and proliferating 
phenotypic subsets. Lastly, dividing the tumor into distinct geographic regions of interest 
(ROI) reveals that the quadrant close to the nutrient-abundant region, which also harbors 
the macroscopically conspicuous rim area, is representative for the entire tumor in terms 
of DFA and molecular-structural correlation results whereas the geographically opposite 
ROI is not.  
In the next section we will first describe the mathematical model in more detail 
followed by the specific oncology concept implemented here.  
 
 
2. MATHEMATICAL MODEL 
 
A. Algorithm 
 
The complete details of our agent-based model are described elsewhere [3,4,11]. Briefly: 
 
• Microenvironment: environmental variables in our model consist of nutrient 
levels, toxic metabolites, and mechanical confinements. First, nutrient sources 
evolve according to the following equation of 
motion: jttjtj lrtDtg ,11,1 )( −−− ∆−∆∇+∆=∆ φφφ φφφ , with gφ representing the 
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constant rate of nutrient replenishment, Dφ the nutrient diffusion coefficient, and 
rφ the nutrient depletion rate. Similarly, the levels of toxic metabolites are also 
updated using a linear difference equation: jttj lrtD ,11 )( −− ∆+∆∇=∆ ττ ττ . 
Finally, the dynamic evolution of mechanical confinements represents the 
‘adaptive grid lattice’ property of the host matrix, such that locations that have 
been invaded by tumor cells in the past will subsequently experience a decline in 
‘tissue consistency’ and thus in mechanical confinement: jtpjtjt lrpp ,1,1, −− −= . 
• Cell behavior: the aforementioned dichotomy between growth and invasion [1,2] 
in our model is captured by alternating sequences of “proliferation-migration-
proliferation” behavior, which in turn drive the formation of distinct 
spatiotemporal patterns. Specifically, the onset of both proliferation and migration 
must satisfy the dual threshold levels of nutrients, ( Lφ , Uφ ), and toxicity, ( Lτ , Uτ ) 
such that a tumor cell in location j proliferates if Uj φφ >  and Lj ττ < , migrates if 
UjL φφφ <<  and UjL τττ << , else the cell dies (representing apoptosis) or 
enters a reversible, quiescent state. For tumor cells that fail to fulfill the 
proliferation criteria but are eligible to migrate, they assign a value Tj to a location 
j based on the following ℜ→Ω:F  function: jjj LF ξ)1( Ψ−+Ψ= , where Ω is 
the set of locations that are adjacent to that tumor cell’s current position, Lj is the 
error-free component (the explicit specification of Lj is derived in [3,4]), and ξj is 
an error term distributed as N(0, σ 2). The parameter Ψ ∈ [0,1] represents the 
precision of chemotactic local search such that the closer Ψ to unity, then the 
more accurate the evaluation of location j would be. Based on a “least resistance, 
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least toxicity and highest attraction paradigm” the migrating tumor cell then 
moves toward the most permissive location j in the choice set Ω, i.e., arg 
max )( jjj LTΩ∈ . 
• Lattice setup: Based on this mathematical description, our simulation platform is 
initially setup as follows. As in previous works, our spatial backdrop is a 200 x 
200 torroidal lattice, representing a virtual section of brain tissue. The initial 
spatial distributions of nutrients and mechanical confinements are detailed 
elsewhere [3,4]. In brief, there are two replenished primary nutrient sources, 
representing cerebral blood vessels, located at the center and at the northeast (NE) 
quadrant of the lattice. To establish a strong chemotactic gradient, the peak of the 
second source at the NE quadrant is set up to be 5-times larger than that of the 
first source at the lattice center. Outside of these two sources, there are much 
smaller sources of non-replenished (‘interstitial’) nutrient substrates that are 
randomly-uniformly distributed. In contrast, we assume that the distribution of 
mechanical confinements follows a uniform distribution everywhere, except 
inside of a small ‘crater’ or void at the center of the grid lattice, adjacent to the 
first primary nutrient source. As in previous works, within the radius of the two 
primary nutrient sources, the initial levels of toxicity are assumed to be zero. As 
the tumor grows, the level of ‘toxic’ metabolites rises representing the reduction 
in pH and pO2 in densely populated areas as well as the byproducts released from 
dying tumor cells. However, and unlike in previous works, outside of the radius of 
the two primary nutrient sources, here we introduce an initial distribution of toxic 
metabolites, representing here in addition the effect of ‘hypoxia’ that are already 
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in the system from the beginning. These initial levels of hypoxia are generated 
based on a uniform probability distribution function. At the beginning of every 
simulation, the grid lattice is seeded with 10 tumor cells that are placed in the 
‘crater’ at the center of the grid lattice. To facilitate initial invasion into the 
surrounding matrix, it is assumed that at t = 0 the crater exhibits low mechanical 
stresses and contains no nutrients. At t = 1, both nutrients and toxic metabolites 
start to diffuse into the crater due to declining mechanical constraints brought 
about by (‘tissue architecture-disrupting’) tumor cell invasion. The simulation 
terminates when the first tumor cell has reached the peak of the second primary 
nutrient source.  
 
The following section details the experimental basis for the gene regulatory network 
operating at the molecular modeling level.  
 
B. Experimental data and ‘gene expression-environment interaction’ concept 
 
Using complementary DNA (cDNA) NIH microarrays, Mariani et al. [2] reported that the 
gene expression of Tenascin C is 4-fold up-regulated in human G112 glioma cells that 
were cultured on an extracellular matrix (ECM) derived from glioma cells. Moreover, 
compared to the control experiment, the authors found that these glioma cells exhibit a 
significantly accelerated migration rate of more than 250 µm/day. Concomitantly, that 
same migratory-stimulated glioma cells show a 2-3.5-fold down-regulation of PCNA. 
Taken together, these findings finding suggest that the migratory phenotype in these 
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glioma cells is associated with both up-regulation of Tenascin C and down-regulation of 
PCNA.  
 
TABLE I. 
 
Table I lists the cDNA NIH microarray gene expression values for both genes reported in 
Mariani et al. [2]. Our approach is to first, calibrate the initial levels of Tenascin C and 
PCNA for migrating tumor cells in our agent-based model according to these data. The 
expression of these genes for proliferating (and quiescent) tumor cells is then obtained 
endogenously, i.e., as the output of our model. The impact of the microenvironmental 
conditions on gene expression is computed as follows. 
 
• Tenascin C has been shown to be strongly expressed in human GaMG 
glioblastoma cells that were cultured in filtrated medium containing 10 percent 
fetal calf serum, yet showed a marked decrease when cultured in serum-free 
conditions [12]. In addition, with the use of serial analysis of gene expression 
(SAGE), Lal et al. [13] found that under hypoxic conditions, the gene encoding 
Tenascin C is induced in human D247-MG glioblastoma cells. Together, these 
findings suggest that an increase in both the onsite levels of nutrients (‘serum’) 
and toxicity (‘hypoxia’) leads to an increase of Tenascin gene expression 
(gTenascin). In our model, for each cell in the grid lattice we transform the levels 
of nutrients, jφ , toxicity, jτ , into the scalars )]/(exp[ˆ φϕϕφ ajjj +=  and 
)]/(exp[ˆ ττττ ajjj += , where φa and τa are parameter constants. Subsequently, 
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gTenascin is computed as a positive, multiplicative function of both nutrients and 
toxic metabolites, jjTbgTenascin τφ ˆˆ= . The transformation procedure and the 
parameter bT ensure that gTenascin ∈ [0,10] and that its initial level equals 4.88 
for migrating tumor cells (see Table I). Note that due to the absence of specific 
comparative experimental data, this formulation assigns equal, positive weights to 
both environmental variables. 
• Folkman [14] had argued that for a tumor to exceed 2-3 mm in diameter, it 
requires angiogenesis as it relies on perfusion for further growth. Indeed, brain 
tumor cell proliferation is especially marked in perfused tumor areas [15]. As has 
been shown for osteoblasts, cell proliferation and thus PCNA expression should 
therefore decrease under hypoxic conditions [16], such as in locations farther 
away from blood vessels, due to a lack of oxygen related to its diffusion limit of 
100-200 µm [17]. Yet, like Tenascin C, the PCNA gene (promoter) also appears 
to be serum-responsive [18]. These data together suggest that an increase in 
nutrients and a decrease in hypoxia, i.e. toxicity lead to an increase of PCNA 
gene expression (gPCNA). Accordingly, we compute jjPbgPCNA τφ ˆ/ˆ= , where 
bP is selected such that gPCNA ∈ [0,10] and that the initial level of gPCNA equals 
0.285 for migrating tumor cells (Table I).  
 
In the following section we will briefly describe the numerical results of the model.  
 
3. RESULTS 
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The typical simulated time series of (a) Tenascin C and (b) PCNA for proliferating and 
migrating tumor cells from a typical run of our model is shown in Fig. 1.  
 
FIG. 1 
 
The gene expression of Tenascin C for migrating cells is always higher than that for 
proliferating cells. In contrast, the gene expression of PCNA for proliferating cells is 
consistently higher than that for migrating cells. These findings suggest that our 
algorithm operates as a genetic switch that simultaneously down-regulates gTenascin and 
up-regulates gPCNA for proliferating cells relative to those of their migrating peers. Not 
shown in Fig. 1 is the gene profile for quiescent tumor cells, whose expression of both 
gTenascin (3.59 ± 0.27) and gPCNA (0.16 ± 0.01) tend to be the lowest relative to 
migrating and proliferating cells. 
 
Another prominent property of the time series is the sharp trend change at a 
particular breakpoint, indicating non-stationary stochastic processes. Figure 2 reveals 
that as the tumor system begins to invade the second nutrient source at the NE region of 
the grid lattice, the average gTenascin across all viable cells experiences a steep rise 
concomitant with a sudden decline in gPCNA (for the simulation shown, at 
approximately t = 308). Figure 3 indicates that this alteration in the gene expression 
profile is accompanied by the emergence of a structural asymmetry, i.e., a bulging area 
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on the tumor surface adjacent to the peak of the second primary nutrient source (located 
in the top right corner, i.e., the NE region of the lattice).  
 
FIG. 2 
 
FIG. 3 
 
The time series depicted both in Figs. 1 and 2 exhibit both fluctuating 
“roughness” that could be described by a power law relationship, as well as non 
stationarity due to the changing means. To characterize the dynamic structure of the time 
series, we employ detrended fluctuation analysis (DFA) that has been previously 
developed to examine non-stationary signals [19]. Furthermore, DFA has been shown to 
be a robust method in detecting long-range correlations in heterogeneous DNA sequences 
[20,21]. Briefly, the DFA method entails the following steps. First, divide each time 
series of gene expression {gi} of length T into T/ω nonoverlapping windows, each 
containing ω data points. Next, in each window of size ω, “detrend” the time series by 
regressing gene expression against a time trend and an intercept term, btag ti +=,,~ ω , then 
compute the minimum sum-of-squared residuals (SSR) for each window equals 
∑+
=
−=
ω
ωω
p
pt
titipi ggSSR
2
,,,,, )~( . Finally, calculate the average piSSR ,,ω  over all windows of 
size ω, ∑=
p
pii SSRTSSR ,,, )//(1 ωω ω . If the time series exhibits the statistical properties 
of a random walk (i.e., no autocorrelations across time), then DFA would yield 
5.0
, ~ ωωiSSR . In contrast, if there is a long-range power-law autocorrelation, then 
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αω ω~,iSSR  with α ≠ 0.5. The presence of a long-range autocorrelation that is 
significantly different from 0.5 indicates the potential use of past values to forecast future 
realizations using for example a linear state-space method [22,23]. 
 
TABLE II. 
 
Columns (1) in Table II show the Monte Carlo simulation results from applying 
DFA to the time series of Tenascin C and PCNA gene expression in distinct regions of 
the tumor corresponding to (I) the entire tumor, (II) the NE region where the second 
nutrient source is located, and (III) the opposite, i.e. southwest (SW) region. Regardless 
of our region of interest (ROI), it can be seen that when DFA is applied separately to 
proliferating and migrating cells, the magnitude of α for proliferating cells indicates a 
stochastic process that is closer to a random walk. However, when DFA is applied to all 
viable tumor cells (i.e., including proliferating, migrating, and quiescent cells) for the 
entire tumor as well as the NE region, we find the magnitudes of α being significantly 
different from 0.5 for both gTenascin and gPCNA, indicating long-range power-law 
autocorrelation over the entire time series that is inherent in a dynamical system far from 
equilibrium. Thus, if we have the past realizations of aggregate gene expression in a 
sample taken from the NE ROI, we can compute the long-range autocorrelation α to 
predict the short-term trajectory of the structural pattern that is likely to emerge for that 
tumor region. Furthermore, these NE ROI sample is representative of the entire tumor, as 
evident from the magnitudes of α. In contrast, in the SW region, which contains only 
low-level nutrient sources, the magnitudes of α resemble those that have been generated 
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by a random walk, and thus have little predictive values for both this particular ROI as 
well as the entire tumor. 
While DFA is a useful method to quantify the dynamic structure of a time series, 
it does not reveal the extent of the co-movements between a pair of variables. It turns out 
that the correlations between the tumor’s macroscopic pattern and its molecular-level 
gene expression depend on both the timing and the geography of the sampling. For the 
entire time series, the correlation between the tumor diameter, which represents 
macroscopic structural characteristics, and gTenascin is 0.56 ± 0.05, while between the 
former and gPCNA is –0.52 ± 0.03, both are averages for all viable cells. At first, these 
rather low correlations seem to suggest a weak relationship between structural pattern and 
molecular-level dynamics. However, since the time series of gTenascin and gPCNA are 
both characterized by non-stationarity as indicated by the changing trend at the 
breakpoint (see Fig. 2), it is necessary to split the series at the breakpoint and then 
compute the correlation coefficient from that point on, separately for each subsample of 
interest. Let 
EB TT
C ,  represent the correlation coefficient when the series is truncated 
between the breakpoint, TB, and the end of the simulation, TE. Columns (2) in Table II 
list 
EB TT
C , between, on one hand, the expression of genes Tenascin C and PCNA 
(averaged over all viable tumor cells) and, on the other hand, the tumor diameter (or the 
tumor radius for the ROIs). For the entire tumor as well as in the NE quadrant of the 
lattice, the magnitude of the correlations indicates a robust positive correlation between 
average tumor diameter and gTenascin (of all viable tumor cells), and at the same time a 
strong negative correlation between the former and gPCNA. In both cases we also found 
that if we compute 
EB TT
C ,  for the proliferating and migrating phenotypes separately, then 
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only the latter exhibit strong correlations between gene expression and the tumor 
diameter, although both phenotypic subgroups exhibit lower correlations than the virtual 
specimen that contains a mixture of all viable tumor cells. These results are robust as 
indicated by the small standard errors from performing Monte Carlo simulations. Lastly, 
the magnitudes of 
EB TT
C , again indicate that the sample taken from the region close to a 
high-level nutrient source (in this case from the NE ROI) is representative of the entire 
tumor. In contrast, the low-nutrient SW ROI exhibits only weak correlations between the 
tumor diameter and the expression of genes Tenascin C and PCNA.  
In the following section we will briefly discuss these results and their potential 
impact on experimental and clinical oncology.   
 
 
4. DISCUSSION AND CONCLUSIONS 
 
Quantitative gene expression arrays provide novel and important information for 
experimental and clinical cancer research alike. However, since such arrays typically 
represent static snapshots taken at a given point in time from a specific specimen taken 
out of its 3D tissue context, they do not describe the dynamics on the molecular level and 
hence do not allow one to deduce their dynamic correlations with the overall expanding 
tumor structure the specimen has been taken from. Integrating this relationship between 
molecular-level gene expression and the macroscopic tumor structure within a dynamic 
framework therefore represents an important application for novel computational models, 
which one can begin to calibrate using already available tumor biology data.  
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For this purpose, here we have incorporated a gene expression module into a 
previously developed 2D agent-based tumor model which focuses on both the 
microscopic cellular level and the multicellular patterns arising from interactions with 
distinct environmental conditions. As a first approximation, this simplified genetic profile 
or ‘network module’ includes the expression of only two genes, Tenascin C and PCNA, 
respectively. Since specific expression levels have been reported for the migratory glioma 
cell phenotype, we calibrated the expression of genes Tenascin C and PCNA in our 
model for this phenotype only while endogenously obtaining the gene expression levels 
for the proliferative and quiescent phenotypes as the output of our model.  
The results shown in Fig. 1 confirm that the Tenascin C gene expression 
experiences an up-regulation while PCNA is down-regulated during cell migration, 
whereas the PCNA gene expression is up-regulated during cell proliferation with a 
concomitantly down-regulated Tenascin C. The first part is in agreement with the cDNA 
data reported from [2], implemented in the modeling concept. The proliferative part or, 
more precisely, the gene-network switch itself, leading to the change in phenotypic 
behavior can be explained by examining the environmental variables that govern the 
expression of Tenascin C and PCNA. Examination of nutrient and toxicity levels during a 
typical run reveals that as tumor cells begin to invade the second nutrient source, nutrient 
levels for migrating cells jump to a level 2.5-fold higher than those for proliferating cells, 
while toxic metabolites, representing in this iteration primarily hypoxic conditions 
(within our virtual 2D tissue section), reach a level 16-fold higher for migrating cells than 
those for proliferating cells. It is the simultaneous increases in nutrients and toxic 
metabolites that cause the breakpoint in the time series of the Tenascin C and PCNA 
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expression (see Fig. 2). This intriguing behavior therefore can be explained by the 
explicit dependencies of gene expression in our model on environmental variables, which 
correspond to the fact reported in the literature that the expression of genes Tenascin C 
and PCNA depend positively on nutrient levels, yet only the Tenascin C is positively 
related to hypoxia levels while PCNA negatively so. However, it is noteworthy that none 
of the model equations impose the condition that the expression of genes Tenascin and 
PCNA in the proliferative cell population, which has been obtained as the output of our 
model, should remain at levels that are as remarkably stable over time as seen in Fig. 1. 
We also found that in the NE region where tumor cells are attracted by high levels 
of nutrient sources, representing for example the growth of the malignant brain tumor 
toward branches of the middle cerebral artery, the average tumor diameter exhibits a 
strong positive correlation with gTenascin, yet an equally strong negative correlation with 
gPCNA. Furthermore, our model also shows that this particular molecular-level behavior 
is accompanied by the emergence of a structural asymmetry, namely a bulging area, at 
the tumor surface adjacent to the largest nutrient source representing the aforementioned 
neighboring blood vessel. These computational findings are in agreement with Hoshino 
and Wilson [24] who stated that as a rule, an increase in brain tumor size is accompanied, 
amongst others, by a lower growth fraction, GF. As the total tumor cell number increases, 
and since the authors had defined GF as the proliferating pool cells divided by the total 
cell population, an additional decrease in PCNA expression as shown in our simulation 
results would contribute to an even more substantial GF reduction while the tumor 
diameter increases. Numerical results of our model confirm that gTenascin is up-
regulated among migrating cells (Fig. 1) to a level higher than for proliferating cells. 
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Thus, in this simplified network, not only is Tenascin C the gene primarily responsible 
for the tumor’s spatial expansion (into the NE quadrant) as measured by the average 
tumor diameter, but it is also critical in the development of distinct structural patterns. 
Cautiously extrapolated to the clinical situation, our numerical results suggest that the 
expression profile of the gene subset associated with migratory cell activity (e.g., 
Tenascin C and others) should be monitored at least as closely in brain tumors during the 
later stages as the often routinely assessed cell proliferation markers.  
Furthermore, the DFA results indicate that when all viable tumor cells are 
combined, the time series of gene expression exhibit long-range autocorrelation as 
indicated by the dynamic fractal dimensions, namely α = 1.32 for gTenascin and α = 1.06 
for gPCNA. In contrast, when DFA is applied separately to migrating and to proliferating 
cells [columns (1) in Table II], the computed α suggests dynamical behavior that is 
much closer to that of a random walk (i.e., with α = 0.5). Therefore, actual biopsy results 
that almost certainly contain all three tumor phenotypes (i.e., proliferating, migrating, and 
quiescent cells) appear to be more desirable than separate phenotypic subsets for gene 
expression profiling in generating time series whose past values can be utilized to predict 
future realizations, at least during a short-term duration. In contrast, predictions that are 
exclusively based on the gene expression for the proliferative cell phenotype appear to be 
relatively weak [columns (1) in Table II]; hence the gene expression of this phenotype 
alone is less useful for detecting co-movements with structural macroscopic patterns 
[columns (2) in Table II]. These findings thus suggest that biopsies from the proliferative 
tumor core are less useful for predicting macroscopic patterns than biopsies from the 
tumor edge, which should harbor a larger fraction of migratory phenotypes (i.e., contain a 
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more heterogeneous mix of cell phenotypes). Furthermore, the magnitude of the α’s also 
suggests the extent of autocorrelation is greater for gTenascin than for gPCNA; thus the 
prediction of gTenascin can be based on past values that had been recorded at larger 
inter-temporal interval than those required for the prediction of gPCNA while 
maintaining the same error level. This points towards potential implications for clinical 
oncology as it indicates that in order to predict the gene expression dynamics of Tenascin 
C in a patient’s brain tumor, the interval between invasive control biopsies could in fact 
be kept longer, hence lowering the burden for the patient without jeopardizing the level 
of predictability. However, in a real medical setting it would be impossible to collect and 
analyze all tumor cells of a patient, and hence it is noteworthy that we found marked 
differences in the predictive value of distinct geographic regions within the tumor. 
Specifically, the ROI NE closely represents the behavior of the entire tumor in terms of 
its DFA results whereas ROI SW does not. Taken together with the appearance of the 
surface asymmetry within the NE ROI, one could argue that in order to maximize its 
predictive value, a particular tumor tissue biopsy has to be prompted by the emergence of 
and then image-guided towards such conspicuous tumor rim regions.   
 It is important to realize the potential shortcomings of our approach. First, the 
precise nature of the gene regulatory network involving gTenascin and gPCNA is in large 
parts still unknown. However, even if more experimental information should become 
available in the future, it remains to be seen whether a model that incorporates the full 
complexity of the interactions among the genes involved in cell growth and locomotion 
would perform better than relatively simple models such as ours, which focuses on two 
‘key’ genes only. Secondly, our model contains only a genetically homogeneous 
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population of tumor cells, which is advantageous if the focus is on phenotypic 
alternations such as in here. Yet, a more biologically realistic model will eventually need 
to incorporate genetic instability and thus heterogeneity.  
Nonetheless, our goal here is to demonstrate that in this virtual brain tumor one 
can successfully combine the molecular-level gene expression dynamics with 
multicellular, macroscopic growth patterns using an agent-based modeling approach. As 
genomics data are becoming increasingly available for various tumor types our ‘mol-
micro-macro’ approach should provide a very helpful tool for investigating the crucial 
relationship between the phenotypic changes specific, microenvironmentally induced 
gene expression profiles cause on the one side and the expansion rate of the overall tumor 
system and its regional structural patterns on the other.  
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FIGURE CAPTIONS 
 
FIG. 1. Time Series of (a) Tenascin C and (b) PCNA gene expression for proliferating 
(open triangles) and migrating (open rectangles) tumor cells. Superimposed on the 
graphs are the time series of the average tumor diameter (solid line, right y-axis). 
 
FIG. 2. Time series profile of gTenascin (left y-axis, solid line) and gPCNA (right y-axis, 
dashed line), averaged across all viable cells (i.e., including proliferating, migrating, and 
quiescent tumor cells). 
 
FIG. 3. 2D snapshots of the tumora during a typical simulation run at t = 308 (left) 
corresponding to the onset of the sharp rise in gTenascin and decline in gPCNA (see Fig. 
2) and at t = 371 (right) just before the first cell invades the peak of the second nutrient 
source. 
a    Note the rapidly expanding, ‘viable’ tumor rim around a darkened, necrotic center. 
 
TABLE I. cDNA Microarray data (of two experiments), taken from [2]. 
 
TABLE II. (1) DFA results using the entire time series. (2) Correlation coefficients 
between gene expression and tumor diameter for the truncated series between the 
breakpoint (see Fig. 2) and the end of the simulation for (I) the entire tumor, (II) the NE 
region only, and (III) the SW region only. The numbers are averages over 20 simulation 
runs, with the standard deviations shown in brackets. 
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a    In addition to investigating the entire tumor we defined two regions of interest, i.e., 
the northeast (NE) quadrant (which hosts the second replenished nutrient source) and 
the southwest (SW) quadrant (which is farthest away from the second replenished 
nutrient source). 
b, c  Includes all viable tumor cells, i.e., proliferative, migrating and quiescent cells. The 
latter are defined as both non-proliferative and non-migratory. 
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FIGURES AND TABLES 
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Simulated Time Series of gTenascin and gPCNA
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FIG. 3 
 
 
 
 
 
 
Clone ID Clone Title cDNA Array (1) 
[Ratio 
ECM/Plastic] 
cDNA Array (2) 
[Ratio 
ECM/Plastic] 
Mean 
23185 Hexabrachion 
(Tenascin C) 
       4.83       4.93 4.880 
789182 Proliferation nuclear 
cell antigen (PCNA) 
       0.28       0.29 0.285 
 
TABLE I 
 
 
 
 
 
 
 (I) Entire tumor (II) NE regiona (III) SW region 
 (1)   α   (2) 
EB TT
C ,  (1)   α   (2) EB TTC ,  (1)   α   (2) EB TTC ,  
Tenascin, proliferating cells 0.57 (0.01)   0.16 (0.01) 0.56 (0.01)   0.35 (0.03) 0.57 (0.01)   0.29 (0.14) 
Tenascin, migrating cells 0.85 (0.03)   0.95 (0.02) 0.85 (0.06)   0.95 (0.01) 0.62 (0.02)   0.54 (0.17) 
Tenascin, all cellsb 1.32 (0.06)   0.99 (0.01) 1.16 (0.06)   0.99 (0.00) 0.63 (0.02)   0.46 (0.08) 
PCNA, proliferating cells 0.63 (0.02)   0.45 (0.02) 0.58 (0.01)   0.46 (0.02) 0.58 (0.01)   0.38 (0.29) 
PCNA, migrating cells 0.73 (0.03) −0.93 (0.03) 0.73 (0.04) −0.93 (0.01) 0.60 (0.02) −0.32 (0.17) 
PCNA, all cellsc  1.06 (0.04) −0.99 (0.00) 0.93 (0.04) −0.99 (0.01) 0.60 (0.01) −0.18 (0.04) 
 
TABLE II 
